Standout Papers

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biode... 1995 2026 2005 2015 1.0k
  1. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas (1995)
    Henry Brem, Steven Piantadosi et al. The Lancet

Citation Impact

Citing Papers

Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide
2002
Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
2015
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells
2008
In vivo release from a drug delivery MEMS device
2004
Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy
2015
IDH1andIDH2Mutations in Gliomas
2009 Standout
Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres
1997
Synthesis and patterning of tunable multiscale materials with engineered cells
2014
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
2010
Hepatocellular carcinoma
2018 Standout
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
2016
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
2018
Current Clinical Trials Testing Combinations of Immunotherapy and Radiation
2014
Gold nanoparticles as novel agents for cancer therapy
2012
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
2013
Rapid translocation of nanoparticles from the lung airspaces to the body
2010 StandoutNobel
A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma
2003 Standout
Biodegradable polymer implants to treat brain tumors
2001
Thermophysical and biological responses of gold nanoparticle laser heating
2011
Immunological landscape and immunotherapy of hepatocellular carcinoma
2015
Molecularly targeted therapy for malignant glioma
2007
Advances in Brain Tumor Surgery
2007
Polymer conjugates as anticancer nanomedicines
2006 Standout
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
2012
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
2017
Non-alcoholic fatty liver disease
2021 Standout
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Treating metastatic cancer with nanotechnology
2011
Exploiting Intrinsic Nanoparticle Toxicity: The Pros and Cons of Nanoparticle-Induced Autophagy in Biomedical Research
2014
Malignant Gliomas in Adults
2008 Standout
Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial
2006
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
2010
Morphological Characterization of Polyanhydride Biodegradable Implant Gliadel® During in Vitro and in Vivo Erosion Using Scanning Electron Microscopy
1996
Pre-eclampsia
2021
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
Gastric cancer
2020 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
A Nanoparticle Size Series for In Vivo Fluorescence Imaging
2010 StandoutNobel
Effects of Birth Spacing on Maternal, Perinatal, Infant, and Child Health: A Systematic Review of Causal Mechanisms
2012
Emerging Biomedical Applications of Enzyme-Like Catalytic Nanomaterials
2017
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Photodynamic therapy (PDT) for malignant brain tumors – Where do we stand?
2015
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Diagnosis and Treatment of High-Grade Astrocytoma
2007
Polyanhydride degradation and erosion
2002
Introduction to Metal–Organic Frameworks
2012 StandoutNobel
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Hepatocellular Carcinoma
2019 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Atomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities
2016 Standout
Complexation of Polyoxometalates with Cyclodextrins
2015 StandoutNobel
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Efficacy of Fractionated Stereotactic Reirradiation in Recurrent Gliomas: Long-Term Results in 172 Patients Treated in a Single Institution
2005
Polymeric Systems for Controlled Drug Release
1999 Standout
Intratumoral Chemotherapy
1995
Organocatalysis by N-Heterocyclic Carbenes
2007 Standout
Hydrogels for Tissue Engineering
2001 Standout
Diagnosis and Treatment of Recurrent High-Grade Astrocytoma
2006
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Structure-Based Design of Functional Amyloid Materials
2014 StandoutNobel
Monodisperse Double Emulsions Generated from a Microcapillary Device
2005 StandoutScience
Emerging functional nanomaterials for therapeutics
2011
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Cyclodextrin Capped Gold Nanoparticles as a Delivery Vehicle for a Prodrug of Cisplatin
2013
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Prognostic value of glypican‑1 for patients with advanced pancreatic cancer following regional intra‑arterial chemotherapy
2018
Gold Nanomaterials at Work in Biomedicine
2015
Biomaterials in Drug Delivery and Tissue Engineering:  One Laboratory's Experience
1999
Salvage Radioimmunotherapy With Murine Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 for Patients With Recurrent Primary and Metastatic Malignant Brain Tumors: Phase II Study Results
2005
(Intra)Cellular Stability of Inorganic Nanoparticles: Effects on Cytotoxicity, Particle Functionality, and Biomedical Applications
2015
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Water Gelation by Small Organic Molecules
2004 Standout
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.
2006
Hypertensive Disorders of Pregnancy
2018 Standout
Controlled Ring-Opening Polymerization of Lactide and Glycolide
2004 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The Chemistry of Neutron Capture Therapy
1998 Standout
Ligation of anti-cancer drugs to self-assembling ultrashort peptides by click chemistry for localized therapy
2013
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
2011 Standout
Plasmonic Heating of Nanostructures
2019
Nanomedicines: addressing the scientific and regulatory gap
2014
Emerging Targets in Photopharmacology
2016 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
2009 StandoutNobel
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
A reversible molecular valve
2005 StandoutNobel
Selective boron drug delivery to brain tumors for boron neutron capture therapy
1997
Clinical Translation of Nanomedicine
2015

Works of Melissa Walker being referenced

Maternal plasma homocysteine levels in women with preterm premature rupture of membranes
2001
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
2011
Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas
1995 Standout
The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone
2009
Screening, Diagnosis, and Management of Intrauterine Growth Restriction
2012
Results of a completed phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine
2009
Cirrhosis is under‐recognised in patients subsequently diagnosed with hepatocellular cancer
2016
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
2010
A pilot study of tremelimumab – a monoclonal antibody against CTLA-4 – in combination with either trans catheter arterial chemoembolization (TACE) or radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC).
2015
Placental Pathology in Relation to Uterine Artery Doppler Findings in Pregnancies with Severe Intrauterine Growth Restriction and Abnormal Umbilical Artery Doppler Changes
2016
A pilot study of tremelimumab, a monoclonal antibody against CTLA-4, in combination with either transcatheter arterial chemoembolization (TACE) or radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC).
2014
A pilot study of AMP-224—a PD-1 inhibitor—in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic colorectal cancer.
2015
Rankless by CCL
2026